Sign up by July 8, 2013 for a 20% discount, or register 3 for the price of 2 with the coupon code RCDVB!

Dear Colleague,

We invite you to join us at the CNS Diseases World Summit 2013, where leading experts across industry and academia to discuss the latest research and developments in the CNS field. The summit has two parallel tracks that focus on neurodegenerative conditions and CNS partnering and deal-making.

Join your colleagues at this exciting meeting on September 9-10, 2013 in Boston, MA and hear from key representatives to discuss the current state of neuroscience drug discovery and build partnerships that will move the field forward.

To view the agenda, click here.
To view the speaker list, click here.

To view the agendas of the parallel conferences, please visit the below links:

6th CNS Partnering & Deal-Making

7th Neurodegenerative Conditions Research & Development

Summit registration gives you access to both conferences!
 

We hope to see you in Boston!

Best regards,

The 2013 Advisory Commitee

Attend ALL GTC Conferences for one year for only $3,995 ($1,990 for academic and government).
Click here to sign up!

What Past Delegates Said About the Event:

"The CNS Diseases World Summit provided an excellent, comprehensive overview on current progress in the areas of psychiatry and neurology, great venue and excellent organization helped to make this an efficient, informative and enjoyable meeting. Great opportunities for cross-company networking."
- Johan Luthman, VP Neuroscience & Ophthalmology R&D, Merck

"Scope like a small scale ICAD (International Conference of Alzheimer’s Diseases) but much easy to digest."
- Feng Luo, M.D., Ph.D, Senior Scientist, Experimental Imaging, Abbott Laboratories

“With high -quality presentations going on simultaneously on three separate tracks, one of the biggest challenges for me was choosing which of them to attend, when quite often, all three looked very worthwhile. That’s a good problem to have. Both in terms of content and contacts, this was a very useful conference.”
- Harry M. Tracy, PhD, President, NI Research